Current through codified legislation effective September 18, 2024
Section 7-1671.04 - [Effective Until 3/1/2025] Recommending authorized practitioner; protections(a) A qualifying patient may receive a recommendation from an authorized practitioner to use medical cannabis for a qualifying medical or dental condition or a qualifying medical or dental treatment. (b) An authorized practitioner may recommend the use of medical cannabis to a qualifying patient, on a form provided by ABCA, if the authorized practitioner makes the recommendation based on an assessment of the qualifying patient's current medical or dental condition. (c) An authorized practitioner shall not be subject to any penalty, including arrest, prosecution, or disciplinary proceeding, or denial of any right or privilege, for advising a qualifying patient about the use of medical cannabis or recommending the use of medical cannabis to a qualifying patient pursuant to this act and any rules issued pursuant to section 14. (d) An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not have a professional office located at a retailer, internet retailer, cultivation center, manufacturer, or testing laboratory or receive financial compensation from a cultivation center, manufacturer, or testing laboratory, or a director, officer, member, incorporator, agent, or employee of a retailer, internet retailer, cultivation center, courier, manufacturer, or testing laboratory. (e)(1) Within 14 calendar days of receiving a notice as described in paragraph (2) of this subsection, a qualifying patient shall: (A) Surrender his or her registration card to the Board; and(B) Notify his or her registered caregiver, if applicable, of the change described in the notice.(2) For the purposes of this subsection, "notice" means: (A) An authorized practitioner declaring that: (i) The qualifying patient no longer suffers from a qualifying medical or dental condition; or(ii) The authorized practitioner no longer recommends use of medical cannabis for a qualifying medical or dental treatment for the qualifying patient; or(B) A qualifying patient notifying ABCA that they no longer need cannabis for the treatment of a qualifying medical or dental condition or for a qualifying medical or dental treatment.Amended by D.C. Law 25-193,§ 2, 71 DCR 006749, eff. 7/19/2024, exp. 3/1/2025.Amended by D.C. Law 25-437,§ 2, 71 DCR 004118, eff. 4/8/2024, exp. 7/7/2024.Amended by D.C. Law 24-332, § 3 , 70 DCR 001582, eff. 3/22/2023.Amended by D.C. Law 23-149, § V-B-5012 , 67 DCR 10493, eff. 12/3/2020.Feb. 25, 2010, D.C. Law 13-315, § 5; as added July 27, 2010, D.C. Law 18-210, § 2, 57 DCR 4798; Feb. 18, 2017, D.C. Law 21-209, § 2(d), 63 DCR 15291.This section is set out more than once due to postponed, multiple, or conflicting amendments.